Bevacizumab treatment for advanced non-small cell lung cancer: A case report

The safety of Avastin in lung cancer (SAiL) study is a multi-center, open-source, stand-alone study. Patients with untreated, locally advanced, metastatic or recurrent non-squamous non-small cell lung cancer (NSCLC) were administered up to six cycles of chemotherapy combined with bevacizumab-humaniz...

Descripción completa

Detalles Bibliográficos
Autores principales: FAN, YUN, HUANG, ZHIYU, MAO, WEIMIN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834347/
https://www.ncbi.nlm.nih.gov/pubmed/24260075
http://dx.doi.org/10.3892/ol.2013.1603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834347/
https://www.ncbi.nlm.nih.gov/pubmed/24260075
http://dx.doi.org/10.3892/ol.2013.1603

Ejemplares similares